Available Until 3/23/2023

Hidden in Plain Sight: Does My Patient Have Nonvalvular Atrial Fibrillation?

ACPE Activity Number: 0204-0000-22-409-H01-P
Release Date: March 23, 2022
Expiration Date: March 23, 2023
Activity Type: Application-based
CE Credits: 1.0 contact hours (0.1 CEUs)
Activity Fee: Free of charge

 This activity is a recording from a live webinar and those that claim credit for the live webinar should not claim credit for this activity.

Activity Overview

Atrial fibrillation (AF)—the most common sustained heart rhythm disorder— is emerging as a growing epidemic. More importantly, a significant number of people remain undiagnosed, putting them at risk for stroke. This educational activity spotlights the need for awareness of nonvalvular atrial fibrillation (NVAF) in patients with risk factors. The role of pharmacists in opportunistic and systemic screening for NVAF is explained, particularly in patients who are underserved. Current guidelines for appropriate, evidence-based therapy for NVAF, including anticoagulation, is also reviewed.

More in this Series:

Shining a Light on Undiagnosed Nonvalvular Atrial Fibrillation: A Case-based Approach to Care


Finding Hidden Stroke Risk: Screening for Atrial Fibrillation
Listen Now →

Don’t Skip a Beat: Practical Considerations When Choosing an Anticoagulant for Nonvalvular Atrial Fibrillation
Listen Now →

Expert Insight Commentary:

Finding Undiagnosed Atrial Fibrillation: Why, What, Who and How
Read Now →

The Time is Now: Equity in the Prescribing of DOACs for NVAF
Read Now →

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

This activity was planned to meet the educational needs of pharmacists who care for patients with or at risk for nonvalvular atrial fibrillation.

Learning Objectives

At the conclusion of this activity, participants will be able to:

  • Summarize the prevalence of undiagnosed nonvalvular atrial fibrillation (NVAF) in patients at high risk for atrial fibrillation (AF) and stroke.
  • Describe how pharmacists can identify patients with NVAF using opportunistic and systematic screening in a diverse patient population.
  • Apply current guidelines for the safe and efficacious treatment of patients with NVAF.

Schedule of Activities 

Welcome and Introductions
James S. Kalus, PharmD, FASHP

Nonvalvular Atrial Fibrillation
James S. Kalus, PharmD, FASHP

Screening for Nonvalvular Atrial Fibrillation in Patients at Risk
James S. Kalus, PharmD, FASHP

Applying the Guidelines to Patients with Nonvalvular Atrial Fibrillation
Devin L. Lavender, PharmD, BCPS, BCACP

Faculty Discussion/ Questions and Answers
James S. Kalus, PharmD, FASHP and Devin L. Lavender, PharmD, BCPS, BCACP


James S. Kalus, PharmD, FASHP, Activity Chair
Director of Pharmacy
Henry Ford Health System
Detroit, Michigan

James S. Kalus, Pharm.D, FASHP, is Director of Pharmacy at Henry Ford Health System in Detroit, Michigan where he is responsible for planning, implementing, and managing all pharmacy services related to patient care including staff training and development, and pharmacy research. Dr. Kalus also serves as Program Director for the postgraduate year one (PGY1) residency at Henry Ford Hospital and is adjunct assistant professor of pharmacy and medicine at Wayne State University. In his research, Dr. Kalus has focused on cardiovascular disease, including the pathophysiology of atrial fibrillation (AF) occurring after cardiac surgery, novel strategies for the treatment and prevention of AF, practice-based research related to anticoagulation and implementation science related to clinical pharmacy services. 

Devin L. Lavender, PharmD, BCPS, BCACP
Clinical Assistant Professor
University of Georgia College of Pharmacy
Athens, Georgia 

Devin Lavender, Pharm.D., BCPS, BCACP is Clinical Assistant Professor at the University of Georgia College of Pharmacy in Athens, Georgia where he practices in Ambulatory Care and chronic disease management at the Athens Community Based Outpatient Clinic affiliated with the Charlie Norwood VA Medical Center. Dr. Lavender obtained his Pharm.D. degree from The University of Georgia College of Pharmacy. He completed a PGY1 Pharmacy Practice Residency at the Memphis VA Medical Center followed by a PGY2 Ambulatory Care Specialty Residency at the University of Georgia College of Pharmacy in conjunction with the Charlie Norwood VA Medical Center. 


No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company.

As defined by the Standards of Integrity and Independence in Accredited Continuing Education definition of ineligible company. All relevant financial relationships have been mitigated prior to the CE activity

This activity consists of a recordings of faculty slides presentations, active learning activities, discussion, and handouts. Participants must participate in the activity in its entirety to claim continuing pharmacy education credit online at ASHP eLearning Portal. Follow the prompts online to complete the evaluation, claim credit and view the statement of credit immediately after completing the activity.

Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Claim your CE at http://elearning.ashp.org. Once you have processed and claimed your CE credit, we encourage you to check your NABP eProfile account to verify your credits were transferred successfully before the ACPE 60-day deadline. It is an electronic direct-report process so your credits should appear in your account within a few minutes. After the 60 day deadline, ASHP will no longer be able to report your credit(s) for this activity.

Provided by ASHP

Supported by an educational grant from the Bristol Myers Squibb and Pfizer Alliance